Dry eye among males infected with the human immunodeficiency virus. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Dry eye among males infected with the human immunodeficiency virus.

J Am Optom Assoc. 1995 Sep;66(9):533-8. Unique Identifier : AIDSLINE MED/96033481
DeCarlo DK; Penner SL; Schamerloh RJ; Fullard RJ; School of Optometry, University of Alabama at Birmingham 35294,; USA.

Abstract: BACKGROUND: Keratoconjunctivitis sicca (KCS) has been reported as a potential ocular manifestation of human immunodeficiency virus (HIV) infection. This study was designed to estimate prevalence of dry eye among HIV-infected males and correlate subjective and objective findings with disease severity. METHODS: All subjects and controls completed the McMonnies Dry Eye Questionnaire (MDEQ) and underwent diagnostic testing for dry eye including biomicroscopic assessment of the anterior segment, lacrimation kinetics, sodium fluorescein break up time, and vital staining with sodium fluorescein and rose bengal. RESULTS: A 38.8 percent prevalence of dry eye was found in the study group. Certain risk factors may be more likely to produce KCS than others and may be a better indication of potential dry eye than disease severity. CONCLUSIONS: Patient symptoms are not adequate predictors of dry eye, indicating the need for KCS diagnostic testing as part of a comprehensive ocular examination for HIV-infected individuals.
Keywords: Adult California/EPIDEMIOLOGY Dry Eye Syndromes/COMPLICATIONS/*EPIDEMIOLOGY/METABOLISM Human HIV Infections/*COMPLICATIONS Lacrimal Apparatus/SECRETION Male Prevalence Questionnaires Risk Factors Tears/SECRETION JOURNAL ARTICLEKWDadultcalifornia/epidemiologydryeyesyndromes/complications/KWDepidemiology/metabolismhumanhivinfections/KWDcomplicationslacrimalapparatus/secretionmaleprevalencequestionnairesriskfactorstears/secretionjournalarticle
960330
M9630687

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .